Product
Lumacaftor + Ivacaftor
2 clinical trials
2 indications
Indication
Healthy VolunteerIndication
Long QT syndromeClinical trial
A Single-Dose, Bioequivalence and Food Effect Bioavailability Study in Healthy Volunteers Comparing the Commercial Lumacaftor 200 mg / Ivacaftor 125 mg Combination Film-Coated Tablet (Orkambi®) to the Lumacaftor 200 mg Film-Coated Tablet Formulation, and the Lumacaftor 200 mg Film-Coated Tablet Formulation in the Fasted to Fed State.Status: Completed, Estimated PCD: 2023-12-18
Clinical trial
Mutation-specific Therapy for the Long QT SyndromeStatus: Recruiting, Estimated PCD: 2024-06-15